Video

Most Common Myth About Clinical Trials

Catriona Jamieson, M.D., Ph.D., Professor of Medicine, University of California, San Diego Health Moores Cancer Center, addresses a common myth about clinical trials.

Catriona Jamieson, M.D., Ph.D., Professor of Medicine, University of California, San Diego Health Moores Cancer Center, addresses a common myth about clinical trials.

People often think clinical trials benefit doctors and science more than they help the people who participate in them. Clinical trials are actually better, more advanced care.

To be able to get through the Food and Drug Administration's regulations today, the burden of proof to be able to do a clinical trial is much higher than in the past. The likelihood of responding well in a safety, tolerability and proof-of-concept study is much better, as well as trial studies in later phases.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of two doctors and text.
Image of man.
Image of thumbnail.
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
Image of woman.
Image of two people.
Image of doctor.
Image of woman.